![](/images/graphics-bg.png)
Does Type of Tumor Histology Impact Survival among Patients with Stage IIIBIV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy?
Joint Authors
Clements, Karen M.
Sugarman, Katherine P.
Lang, Kathleen
Peltz, Gerson
Earle, Craig C.
Nyambose, Joshua
Taylor, Douglas C. A.
Marciniak, Martin D.
Faries, Douglas E.
Thompson, David
Source
Chemotherapy Research and Practice
Issue
Vol. 2010, Issue 2010 (31 Dec. 2010), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2010-07-20
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Chemotherapy regimens may have differential efficacy by histology in nonsmall cell lung cancer (NSCLC).
We examined the impact of histology on survival of patients (N=2,644) with stage IIIB/IV NSCLC who received first-line cisplatin/carboplatin plus gemcitabine (C/C+G) and cisplatin/carboplatin plus a taxane (C/C+T) identified retrospectively in the SEER cancer registry (1997–2002).
Patients with squamous and nonsquamous cell carcinoma survived 8.5 months and 8.1 months, respectively (P=.018).
No statistically significant difference was observed in survival between C/C+G and C/C+T in both histologies.
Adjusting for clinical and demographic characteristics, the effect of treatment regimen on survival did not differ by histology (P for interaction =.257).
There was no statistically significant difference in hazard of death by histology in both groups.
These results contrast the predictive role of histology and improved survival outcomes observed for cisplatin-pemetrexed regimens in advanced nonsquamous NSCLC.
American Psychological Association (APA)
Clements, Karen M.& Peltz, Gerson& Faries, Douglas E.& Lang, Kathleen& Nyambose, Joshua& Earle, Craig C.…[et al.]. 2010. Does Type of Tumor Histology Impact Survival among Patients with Stage IIIBIV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy?. Chemotherapy Research and Practice،Vol. 2010, no. 2010, pp.1-8.
https://search.emarefa.net/detail/BIM-478554
Modern Language Association (MLA)
Clements, Karen M.…[et al.]. Does Type of Tumor Histology Impact Survival among Patients with Stage IIIBIV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy?. Chemotherapy Research and Practice No. 2010 (2010), pp.1-8.
https://search.emarefa.net/detail/BIM-478554
American Medical Association (AMA)
Clements, Karen M.& Peltz, Gerson& Faries, Douglas E.& Lang, Kathleen& Nyambose, Joshua& Earle, Craig C.…[et al.]. Does Type of Tumor Histology Impact Survival among Patients with Stage IIIBIV Non-Small Cell Lung Cancer Treated with First-Line Doublet Chemotherapy?. Chemotherapy Research and Practice. 2010. Vol. 2010, no. 2010, pp.1-8.
https://search.emarefa.net/detail/BIM-478554
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-478554